Latest Breaking News On - Thomas schaus - Page 1 : comparemela.com

Addressing the Cost vs Quality Conundrum: 3EO Health Receives FDA Emergency Use Authorization, Launches Groundbreaking Point of Care Technology

BOSTON (BUSINESS WIRE) Oct 2, 2023

United statesPeter honkanenHarvard wyssJeremy schubertThomas schausAdministration for strategic preparednessHuman servicesBiomedical advanced researchDeo healthHead of researchDepartment of healthEo health incDevelopment authorityBusiness wireChief executive officerChief technology

3EO Health licenses Wyss Institute technology from Harvard,

The technology fills a present gap in diagnostic testing and could contribute to extending the four walls of the health system for COVID-19 and beyond.

Boston universityUnited statesUniversity of massachusetts medical schoolMassachusetts institute of technologyHarvard universityTufts universitySpaulding rehabilitation hospitalNikhil gopalkrishnanJeremy schubertJiyoun jeongThomas schausDonald ingberBenjamin boettnerBeth israel deaconess medical centerWys molecular robotics initiativeSpear bio inc

3EO Health licenses Wyss Institute technology from Harvard, aiming to develop at-home molecular testing with PCR-grade sensitivity and antigen test–level cost

3EO Health licenses Wyss Institute technology from Harvard, aiming to develop at-home molecular testing with PCR-grade sensitivity and antigen test–level cost
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Boston universityUnited statesUniversity of massachusetts medical schoolMassachusetts institute of technologyHarvard universityTufts universitySpaulding rehabilitation hospitalNikhil gopalkrishnanJeremy schubertJiyoun jeongThomas schausDonald ingberBenjamin boettnerBeth israel deaconess medical centerWys molecular robotics initiativeSpear bio inc

Harvard researchers will sell PCR-grade home COVID test device

The Harvard researchers who developed an ultrasensitive, PCR-grade nucleic acid detection technology plan to sell a portable COVID-19 test.

Spear bioJeremy schubertThomas schausHarvard universityWyss instituteDeo healthHarvard office of technology developmentHarvard medical schoolMedical schoolPeng yinBiologically inspired engineeringMolecular robotics initiativeAbbott diagnosticsNuprobe globalTorus biosystemsDigital biology

3EO Health licenses Wyss Institute technology from Harvard,

The technology fills a present gap in diagnostic testing and could contribute to extending the four walls of the health system for COVID-19 and beyond.

Boston universityUnited statesUniversity of massachusetts medical schoolMassachusetts institute of technologyHarvard universityTufts universitySpaulding rehabilitation hospitalNikhil gopalkrishnanJeremy schubertJiyoun jeongThomas schausDonald ingberBenjamin boettnerBeth israel deaconess medical centerWys molecular robotics initiativeSpear bio inc